Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Senza5 CART5 |
| Synonyms | |
| Therapy Description |
Senza5 CART5 are CD5 knockout T-cells expressing a chimeric antigen receptor (CAR) targeting CD5, which potentially decrease tumor growth (Blood (2023) 142 (Supplement 1): 3462). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Senza5 CART5 | CD5 Immune Cell Therapy 4 | Senza5 CART5 are CD5 knockout T-cells expressing a chimeric antigen receptor (CAR) targeting CD5, which potentially decrease tumor growth (Blood (2023) 142 (Supplement 1): 3462). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06420089 | Phase I | Cyclophosphamide + Fludarabine + Senza5 CART5 Senza5 CART5 | CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) (VIPER101) | Recruiting | USA | 0 |